Related Experiment Video
Updated: Jun 2, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings
Shanthi Mendis1, Lars H Lindholm, Simon G Anderson
1Noncommunicable Diseases and Mental Health Cluster, World Health Organization, Geneva, Switzerland. mendis@who.int
Insights
A total cardiovascular risk approach, focusing on high-risk individuals, significantly cuts drug costs and optimizes healthcare spending in low- and middle-income countries compared to single risk factor management.
Area of Science:
- Cardiovascular epidemiology
- Health economics
- Public health policy
Background:
- Cardiovascular diseases (CVDs) pose a significant burden globally, particularly in low- and middle-income countries (LMICs).
- Current CVD risk management often relies on single risk factor thresholds, potentially leading to suboptimal resource allocation and unnecessary drug treatments.
Purpose of the Study:
- To assess the population distribution of 10-year cardiovascular risk in eight LMICs.
- To compare the cost-effectiveness of drug treatment strategies based on total cardiovascular risk versus single risk factor cutoffs.
Main Methods:
- A cross-sectional study involving 8,625 participants aged 40-80 years from Nigeria, Iran, China, Pakistan, Georgia, Nepal, Cuba, and Sri Lanka.
- Utilized World Health Organization (WHO) and International Society of Hypertension risk prediction charts for risk categorization.
- Calculated drug therapy cost estimates for three selected countries.
Main Results:
- A substantial majority (90.0-98.9%) of the study population exhibited a 10-year cardiovascular risk below 20%.
- Only a small fraction (0.2-4.8%) fell into high-risk categories (≥30%).
- Implementing a total risk approach aligned with WHO guidelines demonstrated potential for significant reduction in drug costs by limiting unnecessary treatments.
Conclusions:
- Adopting a total cardiovascular risk strategy, rather than focusing on single risk factors, can substantially reduce healthcare expenditure by optimizing drug costs.
- This approach enables more efficient allocation of limited resources towards individuals who would benefit most from interventions.
- Complementary population-wide measures are essential to shift the overall cardiovascular risk distribution within the population.
Objectives:
To determine the population distribution of cardiovascular risk in eight low- and middle-income countries and compare the cost of drug treatment based on cardiovascular risk (cardiovascular risk thresholds ≥ 30%/≥ 40%) with single risk factor cutoff levels.
Study Design And Setting:
Using World Health Organization (WHO) and the International Society of Hypertension risk prediction charts, cardiovascular risk was categorized in a cross-sectional study of 8,625 randomly selected people aged 40-80 years (mean age, 54.6 years) from defined geographic regions of Nigeria, Iran, China, Pakistan, Georgia, Nepal, Cuba, and Sri Lanka. Cost estimates for drug therapy were calculated for three countries.
Results:
A large fraction (90.0-98.9%) of the study population has a 10-year cardiovascular risk <20%. Only 0.2-4.8% are in the high-risk categories (≥ 30%). Adopting a total risk approach and WHO guidelines recommendations would restrict unnecessary drug treatment and reduce the drug costs significantly.
Conclusion:
Adopting a total cardiovascular risk approach instead of a single risk factor approach reduces health care expenditure by reducing drug costs. Therefore, limited resources can be more efficiently used to target high-risk people who will benefit the most. This strategy needs to be complemented with population-wide measures to shift the cardiovascular risk distribution of the whole population.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...